Immune to Cancer: The CRI Blog
-
ASCO 2016 Update: Beyond Checkpoint Blockade: Novel Immunotherapy Strategies for Solid Cancers
New strategies use alternative ways to promote anti-cancer immunity.
-
ASCO 2016 Update: Immunotherapy Strategies for Women’s Cancers
Improving immunotherapy for breast, ovarian, and gynecological cancer patients.
-
ASCO 2016 Update: Checkpoint Immunotherapy Advances in Solid Cancers
New insights, approaches to improve outcomes in melanoma, kidney, bladder, and colorectal cancers.
-
ASCO 2016 Update: Biomarker-Based Strategies
Molecular clues may help predict patient treatment and outcomes.
-
ASCO 2016 Update: Advances in Immunotherapy for Lung and Blood Cancers
Combination checkpoints, improved CAR T cells show promise.
-
ASCO 2016 Update: The Value of Combination Immunotherapy
Activating multiple immune pathways to improve patient outcomes.
-
ASCO 2016 Update: The Personal Side of Immunotherapy
To help more patients, treatments must get personal.
-
Inmunoterapia vs. Quimioterapia: ¿Cual es la diferencia?
Respondemos las preguntas frecuentes de los pacientes sobre las diferencias entre la inmunoterapia y la quimioterapia, incluidos…
-
ASCO 2016: The Year of Immunotherapy
Chicago hosts top clinical cancer conference, immunotherapy shines.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.